BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 19263367)

  • 1. Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner.
    Sentürk S; Oğuz KK; Cila A
    Diagn Interv Radiol; 2009 Mar; 15(1):3-12. PubMed ID: 19263367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.
    Hakyemez B; Erdogan C; Ercan I; Ergin N; Uysal S; Atahan S
    Clin Radiol; 2005 Apr; 60(4):493-502. PubMed ID: 15767107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
    Thomsen H; Steffensen E; Larsson EM
    Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing perfusion metrics obtained from a single compartment versus pharmacokinetic modeling methods using dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade.
    Law M; Young R; Babb J; Rad M; Sasaki T; Zagzag D; Johnson G
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):1975-82. PubMed ID: 17032878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas.
    Young R; Babb J; Law M; Pollack E; Johnson G
    J Magn Reson Imaging; 2007 Oct; 26(4):1053-63. PubMed ID: 17896374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.
    Hakyemez B; Erdogan C; Bolca N; Yildirim N; Gokalp G; Parlak M
    J Magn Reson Imaging; 2006 Oct; 24(4):817-24. PubMed ID: 16958061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
    Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
    AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
    Danchaivijitr N; Waldman AD; Tozer DJ; Benton CE; Brasil Caseiras G; Tofts PS; Rees JH; Jäger HR
    Radiology; 2008 Apr; 247(1):170-8. PubMed ID: 18372467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomas.
    Law M; Oh S; Johnson G; Babb JS; Zagzag D; Golfinos J; Kelly PJ
    Neurosurgery; 2006 Jun; 58(6):1099-107; discussion 1099-107. PubMed ID: 16723889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
    Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
    Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].
    Lev MH; Ozsunar Y; Henson JW; Rasheed AA; Barest GD; Harsh GR; Fitzek MM; Chiocca EA; Rabinov JD; Csavoy AN; Rosen BR; Hochberg FH; Schaefer PW; Gonzalez RG
    AJNR Am J Neuroradiol; 2004 Feb; 25(2):214-21. PubMed ID: 14970020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
    Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
    Warmuth C; Gunther M; Zimmer C
    Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of MR perfusion imaging and vessel tortuosity parameters in assessment of intracranial neoplasms.
    Parikh AH; Smith JK; Ewend MG; Bullitt E
    Technol Cancer Res Treat; 2004 Dec; 3(6):585-90. PubMed ID: 15560716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases.
    Jakubovic R; Sahgal A; Soliman H; Milwid R; Zhang L; Eilaghi A; Aviv RI
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):704-12. PubMed ID: 25023291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI.
    Hakyemez B; Erdogan C; Gokalp G; Dusak A; Parlak M
    Clin Radiol; 2010 Jan; 65(1):15-20. PubMed ID: 20103416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
    Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
    Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response.
    Law M; Oh S; Babb JS; Wang E; Inglese M; Zagzag D; Knopp EA; Johnson G
    Radiology; 2006 Feb; 238(2):658-67. PubMed ID: 16396838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation between Supratentorial Single Brain Metastases and High Grade Astrocytic Tumors: an Evaluation of Different DSC MRI Measurements.
    Zhang H; Rödiger LA; Zhang G; Oudkerk M
    Neuroradiol J; 2009 Aug; 22(4):369-77. PubMed ID: 24207139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.